Loading…
Getting the latest data.
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| Total return | −2.1% | −4.4% | +0.3% | +4.1% | +17.4% | +20.2% | +48.4% | +39.6% | +201.2% | +656.7% |
| Peer average | −0.9% | −5.3% | −1.4% | −2.4% | +17.0% | +21.8% | +68.8% | +23.4% | +169.9% | — |
| S&P 500 · VOO | −0.3% | −3.9% | −5.0% | −4.0% | +8.0% | +10.9% | +72.4% | +68.9% | +302.1% | — |
$165 of every $1,000 in IYH is Eli
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | LLYELI Lilly | Healthcare | 16.48% | $1,647.90 | 564K | $798.2M |
| 2 | JNJJohnson & Johnson | Healthcare | 9.79% | $979.25 | 1.7M | $474.3M |
| 3 | ABBVAbbvie | Healthcare | 7.56% | $755.99 | 1.3M | $366.2M |
| 4 | MRKMerck | Healthcare | 5.17% | $517.22 | 1.7M | $250.5M |
| 5 | UNHUnitedhealth Group | Healthcare | 5.13% | $513.09 | 638K | $248.5M |
| 6 | TMOThermo Fisher Scientific | Healthcare | 3.72% | $372.36 | 263K | $180.4M |
| 7 | AMGNAmgen | Healthcare | 3.60% | $360.44 | 381K | $174.6M |
| 8 | GILDGilead Sciences | Healthcare | 3.08% | $308.43 | 878K | $149.4M |
| 9 | ABTAbbott Laboratories | Healthcare | 2.65% | $264.59 | 1.2M | $128.2M |
| 10 | PFEPfizer | Healthcare | 2.36% | $236.38 | 4.0M | $114.5M |
| 11 | ISRGIntuitive Surgical | Healthcare | 2.21% | $221.31 | 249K | $107.2M |
| 12 | DHRDanaher | Healthcare | 2.08% | $208.05 | 446K | $100.8M |
| 13 | VRTXVertex Pharmaceuticals | Healthcare | 1.98% | $198.02 | 180K | $95.9M |
| 14 | MDTMedtronic | Healthcare | 1.83% | $183.18 | 867K | $88.7M |
| 15 | BMYBristol Myers Squibb | Healthcare | 1.83% | $182.69 | 1.4M | $88.5M |
of the $112B in 39 Health care ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | LLY | ELI Lilly | 16.48% |
| 2 | JNJ | Johnson & Johnson | 9.79% |
| 3 | ABBV | Abbvie | 7.56% |
| 4 | MRK | Merck & | 5.17% |
| 5 | UNH | Unitedhealth Group | 5.13% |
| 6 | TMO | Thermo Fisher Scientific | 3.72% |
| 7 | AMGN | Amgen | 3.60% |
| 8 | GILD | Gilead Sciences | 3.08% |
| 9 | ABT | Abbott Laboratories | 2.65% |
| 10 | PFE | Pfizer | 2.36% |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Sep 15, 2026 | Sep 18, 2026 | $0.19 |
| Jun 15, 2026 | Jun 18, 2026 | $0.16 |
| Mar 17, 2026 | Mar 20, 2026 | $0.19 |
| Dec 16, 2025 | Dec 19, 2025 | $0.25 |
| Sep 16, 2025 | Sep 19, 2025 | $0.19 |
| Jun 16, 2025 | Jun 20, 2025 | $0.17 |
| Mar 18, 2025 | Mar 21, 2025 | $0.16 |
| Dec 17, 2024 | Dec 20, 2024 | $0.20 |
| Sep 25, 2024 | Sep 30, 2024 | $0.23 |
| Jun 11, 2024 | Jun 17, 2024 | $0.13 |
| Mar 21, 2024 | Mar 27, 2024 | $0.17 |
| Dec 20, 2023 | Dec 27, 2023 | $0.18 |